Neoplasm Coding and the Neoplasm Table (November 2014)

Why This Topic Matters

Neoplasm coding depends heavily on accurate documentation and correct interpretation of site, status, and sequencing details. The article helps readers understand the scope of ICD-10-CM changes that affect how neoplasms are categorized and reported.

Article Sections

1. November 2014 pages 11-13

   Introductory publication information and the article’s placement within the source issue.

2. Neoplasm Coding and the Neoplasm Table

   Overview of the ICD-10-CM neoplasm table and the broader documentation demands associated with neoplasm diagnosis coding.

3. Key Differences in Neoplasm Coding in ICD-10-CM

   General comparison points between ICD-9-CM and ICD-10-CM neoplasm coding, including added specificity and table organization.

4. Laterality

   Discussion of how ICD-10-CM distinguishes anatomical side in neoplasm coding and why that affects code selection.

5. Primary Malignant Neoplasms with Overlapping Boundaries

   Coverage of how overlapping primary malignant sites are classified, including related examples involving contiguous and noncontiguous sites.

6. Malignant Neoplasms of Ectopic Tissue

   Guidance on how malignant neoplasms arising in ectopic tissue are categorized in relation to the originating site.

7. Anemia Associated with Malignancy

   Sequencing considerations for anemia associated with malignancy when the encounter focuses on the anemia and related tumor coding.

8. Anemia Associated with Chemotherapy, Immunotherapy, and Radiation Therapy

   Discussion of sequencing when anemia is associated with treatment effects, including chemotherapy and radiation-related considerations.

9. Malignancy in Two or More Noncontiguous Sites

   How multiple tumors in the same organ are approached when the sites are separate and their relationship is uncertain.

10. Disseminated Malignant Neoplasm, Unspecified

    Overview of coding when advanced metastatic disease is present and the primary or secondary site is not identified.

11. Malignant Neoplasm without Specification of Site

    Discussion of coding when neither the primary nor secondary site can be determined and the limited use of unspecified malignancy coding.

12. Sequencing Neoplasm Codes

    Summary of sequencing topics for neoplasm-related encounters, including treatment, pregnancy, complications, and pathologic fracture situations.

13. Current Malignancy vs Personal History of Malignancy

    Distinction between active malignancy and personal history coding after treatment is completed and no further disease is present.

14. Leukemia, Multiple Myeloma, and Malignant Plasma Cell Neoplasms in Remission vs Personal History

    Discussion of remission and history coding considerations for selected hematologic malignancies and when documentation may need clarification.